Closure of the left atrial appendage by means of the AtriClip System

Česká verzia

Authors: Aleš Mokráček ^1,2; Vojtěch Kurfirst ¹; Alan Bulava ³; Jiří Haniš ³
Authors place of work: Kardiochirurgické oddělení Nemocnice České Budějovice, a. s. ¹; Zdravotně sociální fakulta Jihočeské univerzity České Budějovice ²; Kardiologické oddělení Nemocnice České Budějovice, a. s. ³
Published in the journal: Vnitř Lék 2017; 63(1): 31-35
Category: Původní práce

Summary

Introduction:
Atrial fibrillation (AFib) is related to a high risk of stroke. The main role in etiopathogenesis is played by the left atrial appendage (LAA). As many as 95 % of thrombi in nonvalvular atrial fibrillation are located in the appendage. Prevention of stroke then consists in permanent anticoagulation which, however, has its limits and risks. An alternative method is the left atrial appendage occlusion. In our report, we would like to present a new possibility of the closure using the epicardial system AtriClip (AtriCure).

Methodology:
In the period beginning in July 2012 – September 2015 we performed LAA closure in 101 patients. A mean age of 65 ± 6 years, 47 women, CHA2DS2 VASc (Ø) 2.47 (0–6). Monitoring 1 837 (Ø 18.5) months. A concomitant procedure was performed in 37 patients, endoscopic MAZE plus clip in 57 patients, and 7 patients underwent stand-alone implantation of the clip. The clip was implanted from full sternotomy, minitoracotomy or through thoracoscopy. Clip loading, residual recess and endoleak were assessed through endoscopic ultrasound according to the Cleveland criteria.

Results:
The perioperative success rate of loading reached 98 %. The clip was loaded with a neck greater than 1 cm in 2 patients. No migration of the clip occurred, no endoleak was detected and no thrombus at the appendage base was detected. One case of periprocedural stroke was recorded. Within follow-up monitoring TIA occurred in 4 patients and no stroke was recorded.

Conclusion:
Epicardial LAA occlusion using the AtriClip system is a safe and reproducible method of LAA occlusion and an important alternative in the prevention of stroke.

Key words:
atrial fibrillation – occlusion of left atrial appendage – stroke

Zdroje

1. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61(2): 755–759.

2. Shirani J, Alaeddini J. Structural remodelling left atrial appendage in patients with chronic non-valvular atrial fibrillation, implication for thrombus formation, systemic embolism and assessment by transesophageal echocardiography. Cardiovasc Patol 2000; 9(2): 95–101.

3. Camm AJ, Lip GIH, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33(21): 2719–2747. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehs253>. Erratum in Eur Heart J 2013; 34(10): 790. Eur Heart J 2013; 34(36): 2850–2851.

4. Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118(5): 833–840.

5. Johnson WJ, Ganjoo AK, Stone CD. The left atrial appendage: our most lethal human attachment: Surgical implication. Eur J Cardiothoracic Surg 2000; 17(6): 718–722.

6. Brown MT, Bussel JK. Medication adherence: Who cares? Mayo Clinic Proc 2011; 86(4): 304–314. Dostupné z DOI: <http://dx.doi.org/10.4065/mcp.2010.0575>.

7. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran vs. Warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361(12): 1139–1151. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa0905561>. Erratum in N Engl J Med 2010; 363(19):1877.

8. Kanderian AS, Gillinov AM, Pettersson G et al. Success of surgical left atrial appendage closure. JACC 2008; 52(11): 924–929. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2008.03.067>.

9. Gillinov MA, Pettersson G, Cosgrove DM. Stapled exciton of the left atrial appendage. J Thorac Cardiovasc Surg 2005; 129(3): 679–680.

10. Katz ES, Tsiamtsiouris T, Applebaum RM et al. Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiographic study. J Am Coll Cardiol 2000; 36(2): 468–471.

11. Salzberg SP, Plass A, Emmert MY et al. Left atrial appendage clip occlusion: early clinical results. J Thorac and Cadiovasc Surg 2010; 139(5): 1269–1274. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jtcvs.2009.06.033>.

12. Ailawadi G, Gerdisch MW, Harvey RL et al. Exclusion of the left atrial appendage with a novel device: Early results of a multicenter study. J Thorac and Cadiovasc Surg 2011; 142(5): 1002–1009e1. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jtcvs.2011.07.052>.

13. Mokráček A, Kurfirst V, Bulava A et al. Thoracoscopic occlusion of the left atrial appendage. Innovations 2015; 10(3): 179–182. Dostupné z DOI: <http://dx.doi.org/10.1097/IMI.0000000000000169>.

14. Starck CT, Steffel J, Emmert MY et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interactive CardioVascular and Thoracic Surg 2012; 15(3): 416–419. Dostupné z DOI: <http://dx.doi.org/10.1093/icvts/ivs136>.

15. Takahashi Y, Sanders P, Rotter M et al. Disconnection of the left atrial appendage for elimination of foci maintaining atrial fibrillation. J Cardiovasc Elecrophysiol 2005; 16(8): 917–919.

16. Stack CHT, Steffel J, Emmert MY et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg 2012; 15(3): 416–418. Dostupné z DOI: <http://dx.doi.org/10.1093/icvts/ivs136>.

17. DiBiase LD, Burkhardt D, Mohanty P et al. Left atrial appendage. An underrecognised trigger site of atrial appendage. Circulation 2010; 122(2): 109–118. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.109.928903>.

18. Ostermayer SH, Reisman M, Kramer PH et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 2005; 46(1): 9–14.

19. Garcia-Fernandez MA, Perez-David E, Quiles J et al. Role of left atrial appendage obliteration in patients with mitral valve prosthesis. J Am Coll Cardiol 2003; 42(7): 1253–1258.

20. Katz ES, Tsiamtsiouris T, Applebaum RM et al. Surgical left atrial appendage ligation is frequently incomplete. JACC 2000; 36(2): 468–471.

21. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114(7): e257-e354. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177292>. Erratum in Circulation 2007; 116(6): e138.

22. 2016 ESC Guidelines for the management of the atrial fibrillation developed in collaboration with EACTS. European Heart J 37(38): 2893–2962.

23. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. Heart Rhythm 2012; 9(4): 632–696.e21. Dostupné z DOI: <http://dx.doi.org/10.1016/j.hrthm.2011.12.016>.

24. Alli O, Doshi S, Kar S et al. Quality of life assessment in the randomized PROTECT AF trial of patients at risk for stroke with nonvalvular atrial fibrillation. J Am Coll Cardiol 2013; 61(17): 1790–8. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2013.01.061>.